- In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
-
Kim JY, Chang J
- KMID: 2374109
- Yonsei Med J.
- 2016 Jul;57(4):809-816.
- doi: 10.3349/ymj.2016.57.4.809
Human respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infection, such as bronchiolitis, bronchitis, or pneumonia, in both infants and the elderly. Despite the global... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
-
Kim NK, Choi JY
- KMID: 2284868
- Korean J Pediatr.
- 2011 May;54(5):197-200.
- doi: 10.3345/kjp.2011.54.5.197
Respiratory syncytial virus (RSV) is a major cause of respiratory infection in children. Most of the pediatric population have RSV infection before the age of 2, and recurrent infections are... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
-
Kwon YM, Hwang HS, Lee YT, Kim KH, Lee Y, Kim MC, Lee YN, Quan FS, Moore ML, Kang SM
- KMID: 2450203
- Immune Netw.
- 2019 Jun;19(3):e18.
- doi: 10.4110/in.2019.19.e18
Formalin-inactivated respiratory syncytial virus (RSV) vaccination causes vaccine-enhanced disease (VED) after RSV infection. It is considered that vaccine platforms enabling endogenous synthesis of RSV immunogens would induce favorable immune responses... -
- CITED
-
- Close
- SHARE
-
- Close
